The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor ...

A UC San Diego study reveals GLP-1 receptor agonists, like Ozempic, may significantly reduce colon cancer death rates.

The key finding was that women who ate the most ultra-processed food—about 10 servings a day—had a 45% higher risk of ...

In a retrospective analysis, patients with colon cancer taking GLP-1 agonists had a 62% lower risk of 5-year mortality ...

People with colon cancer who took GLP-1 drugs were less likely to die within 5 years than people not on GLP-1s, a new study ...

ACTOR James Van Der Beek has been forced to sell off his iconic Dawson’s Creek outfits to raise money for expensive ...

Colon cancer is the fourth leading cause of cancer deaths in the U.S. Eating an anti-inflammatory diet is linked with a 16% ...

There have never been more supplements lining supermarket shelves as millions endeavour to boost their health through a ...

Colorectal cancer used to be associated with old age, but diagnoses have become increasingly common in adults aged 50 or ...

While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new ...

A former Seminole County teacher pleaded guilty to four charges stemming from a misconduct investigation last year, involving ...

The FDA has approved a groundbreaking blood test for colon cancer screening, offering a less invasive and more accessible ...